Minoryx receives approval from Spanish Agency to initiate phase 2 study in Friedreich’s Ataxia
Pherecydes Pharma reports successful patient treatment with bacteriophages
Minoryx Therapeutics extends its activities in Belgium
Biomunex signs a licensing agreement with Sanofi for the development of bi- and multi-specific antibodies
Minoryx Therapeutics announces early completion of patient randomization in the ADVANCE trial
Genoscience Pharma named EuropaBio’s Most Innovative European Biotech SME for 2018
iDD biotech receives second milestone payment from Genmab with enrolment of fifth patient in Gen1029 safety trial
Yposkesi enters into agreement in principle for strategic partnership with Axovant to expand Axovant’s gene therapy manufacturing capacity
